ritanserin has been researched along with Ache in 6 studies
Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Convulsions were followed by statistically significant increase in the tail-flick latencies (TFL), at least for 120 min of the post-ictal period." | 1.33 | Involvement of 5-HT(2) serotonergic receptors of the nucleus raphe magnus and nucleus reticularis gigantocellularis/paragigantocellularis complex neural networks in the antinociceptive phenomenon that follows the post-ictal immobility syndrome. ( Coimbra, NC; de Oliveira, R; de Oliveira, RC; Ferreira, CM, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rahman, W | 1 |
| Bannister, K | 1 |
| Bee, LA | 1 |
| Dickenson, AH | 1 |
| Soleimannejad, E | 1 |
| Semnanian, S | 1 |
| Fathollahi, Y | 1 |
| Naghdi, N | 1 |
| de Oliveira, RC | 1 |
| de Oliveira, R | 1 |
| Ferreira, CM | 1 |
| Coimbra, NC | 1 |
| Neuman, RS | 1 |
| Zebrowska, G | 1 |
| Zhukov, VN | 1 |
| Troian, IuIu | 1 |
| Barber, A | 1 |
| Harting, J | 1 |
| Wolf, HP | 1 |
6 other studies available for ritanserin and Ache
| Article | Year |
|---|---|
A pronociceptive role for the 5-HT2 receptor on spinal nociceptive transmission: an in vivo electrophysiological study in the rat.
Topics: Action Potentials; Amphetamines; Animals; Evoked Potentials; Ketanserin; Male; Nerve Fibers, Unmyeli | 2011 |
Microinjection of ritanserin into the dorsal hippocampal CA1 and dentate gyrus decrease nociceptive behavior in adult male rat.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Hippocampus; Ma | 2006 |
Involvement of 5-HT(2) serotonergic receptors of the nucleus raphe magnus and nucleus reticularis gigantocellularis/paragigantocellularis complex neural networks in the antinociceptive phenomenon that follows the post-ictal immobility syndrome.
Topics: Analgesia; Analysis of Variance; Animals; Behavior, Animal; Brain; Male; Medulla Oblongata; Models, | 2006 |
Serotonin (5-HT2) receptor mediated enhancement of cortical unit activity.
Topics: Animals; Cerebral Cortex; Cinanserin; Cyproheptadine; Iontophoresis; Ketanserin; Male; Microelectrod | 1992 |
[Pharmacological regulation of opioidergic antinociceptive mechanisms].
Topics: Animals; Blood-Brain Barrier; Clonidine; Drug Synergism; Endorphins; Male; Mice; Morphine; Naloxone; | 1991 |
Antinociceptive effects of the 5-HT2 antagonist ritanserin in rats: evidence for an activation of descending monoaminergic pathways in the spinal cord.
Topics: Animals; Methysergide; Nociceptors; Pain; Piperidines; Rats; Receptors, Serotonin; Ritanserin; Spina | 1989 |